What is the heterogeneity in the impact seen with pneumococcal conjugate vaccines telling us?

被引：5

作者：

Hausdorff, William P. ^{[1
]}

Black, Steve ^{[2
]}

机构：

[1] Ave JP Rullens 9, B-1200 Brussels, Belgium

[2] Cincinnati Childrens Hosp, Ctr Global Hlth, Cincinnati, OH USA

来源：

VACCINE | 2017年 / 35卷 / 31期

关键词：

Pneumococcus; Effectiveness; Acute otitis media; Invasive disease; Herd; Protection; OTITIS-MEDIA; CHILDHOOD PNEUMONIA; VACCINATION; CHILDREN; PREVENTION; SEROTYPE;

D O I：

10.1016/j.vaccine.2017.05.089

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Pneumococcal conjugate monia in young children. vaccines on other disease variability would greatly the effort to design more vaccines have proven highly effective in decreasing invasive disease and pneuHowever, there is considerable geographic variability in the impact of these endpoints and in other age groups. Investigation of the possible causes of this improve our understanding of pneumococcal pathophysiology and stimulate broadly effective vaccines. (C) 2017 Elsevier Ltd. All rights reserved.

引用

收藏

页码：3797 / 3800

页数：4

相关论文

共 26 条

[1] Smoke-free households with children and decreasing rates of paediatric clinical encounters for otitis media in the United States [J].

Alpert, Hillel R. ;

Behm, Ilan ;

Connolly, Gregory N. ;

Kabir, Zubair .

TOBACCO CONTROL, 2011, 20 (03) :207-211

[2]

[Anonymous], 1999, Morbidity and Mortality Weekly Report, V48, P1007

[3] Changes in Childhood Pneumonia and Infant Mortality Rates Following Introduction of the 13-valent Pneumococcal Conjugate Vaccine in Nicaragua [J].

Becker-Dreps, Sylvia ;

Amaya, Erick ;

Liu, Lan ;

Moreno, Gilberto ;

Rocha, Julio ;

Briceno, Rafaela ;

Aleman, Jorge ;

Hudgens, Michael G. ;

Woods, Christopher W. ;

Weber, David J. .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (06) :637-642

[4] Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: An active prospective nationwide surveillance [J].

Ben-Shimol, Shalom ;

Greenberg, David ;

Givon-Lavi, Noga ;

Schlesinger, Yechiel ;

Somekh, Eli ;

Aviner, Shraga ;

Miron, Dan ;

Dagan, Ron .

VACCINE, 2014, 32 (27) :3452-3459

[5]

Black S, 2016, ID WEEK 2016 OCT 26

[6] Estimating the population-level impact of vaccines using synthetic controls [J].

Bruhn, Christian A. W. ;

Hetterich, Stephen ;

Schuck-Paim, Cynthia ;

Kueruem, Esra ;

Taylor, Robert J. ;

Lustig, Roger ;

Shapiro, Eugene D. ;

Warren, Joshua L. ;

Simonsen, Lone ;

Weinberger, Daniel M. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (07) :1524-1529

[7]

Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P893

[8] Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease [J].

Dagan, Ron ;

Pelton, Stephen ;

Bakaletz, Lauren ;

Cohen, Robert .

LANCET INFECTIOUS DISEASES, 2016, 16 (04) :480-492

[9]

Diaz J, 2016, PLOS ONE, V11

[10] Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults [J].

Durando, P. ;

Faust, S. N. ;

Fletcher, M. ;

Krizova, P. ;

Torres, A. ;

Welte, T. .

CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 :1-9